Cyclica Inc: federal grants and contributions: 12 agreements; $2.5M value; 4 departments; 6 programs.
Assay record ASY-CA-0MGUA3S0QP · Cite as: Assay Systems, “Cyclica Inc: federal grants and contributions”, https://assay-systems.com/register/ca/grants/r/cyclica-inc/
The project supports Cyclica to accelerate the commercialization of its AI-powered drug discovery platform and scale-up its operations.
CIIP Brazil project “DD for Leishmaniasis” with Neguebe Quimica e Biológica LTDA. Cyclica will combine its computational drug discovery tools with Neguebe’s medicinal chemistry and testing capabilities to rapidly bring new medicines for Leishmaniases to the market. Cyclica will use Ligand Design drug discovery platform with Neguebe to support lead creation, prioritization, and further development of new chemical entities that will increase the arsenal of available drugs for Leishmaniases.
Ligand Express is Cyclica’s web platform used by scientists to aid in drug discovery projects. This project requires cross team collaboration to improve existing tools and innovate new solutions for small molecule drug development.
Subsidy payments to industry for research and development
Original Amount of $7,673, Amendment #1 to increase value by $4,815
The purpose of this CanExport Innovation (CXI) grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
Subsidy payments to industry for research and deve
Subsidy payments to industry for research and development
Subsidy payments to industry for research and development
The purpose of this CanExport Innovation grant agreement is to support organizations and to build on targeted relationships between Canadian companies/researchers and key organizations in other countries to allow them to proceed with formal discussions to initiate collaboration(s) on future international R&D initiatives that could lead to commercialization of Canadian technologies.
The purpose of the Canadian International Innovation Program (CIIP) contribution agreement is to support Canadian SMEs identify international partners in CIIP target countries for industrial research and development collaboration that has good potential for commercialization.
Contains information licensed under the Open Government Licence – Canada. Source: Government of Canada proactive disclosure of grants and contributions (open.canada.ca, dataset 432527ab-7aac-45b5-81d6-7597107a7013), 1,327,352 rows as published, collapsed to one agreement per agreement number (per reference number where none is given) at its latest amendment, which carries the full agreement value. Years are the agreement start year. Agreements with individuals are counted but not named.